메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

김민영 (충북대학교, 충북대학교 대학원)

지도교수
정헌상
발행연도
2018
저작권
충북대학교 논문은 저작권에 의해 보호받습니다.

이용수2

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (3)

초록· 키워드

오류제보하기
This study was performed (1) to investigate the combined effect of germination and high hydrostatic pressure (HHP) treatment on the conversion of phenolics, protein and soyasaponin in black soybean, (2) to investigate changes of physiological activities of phenolics, protein and soyasaponin rich extracts in conversion of functional compound, (3) to identify maker ingredient according to isolation of bioactive components in functional compound rich extracts, and (4) to clarify the cause converted maker compound of soybean with germination and HHP treatment. Black soybean was germinated at 25°C for two- or four-days, and subjected to HHP at 0.1, 50, 100, or 150 MPa for 24 h.
1. Conversion and physiological characteristics of phenolic compound in black soybean after germination and high hydrostatic pressure treatment were investigated. Total free polyphenol, flavonoid, and phenolic acid contents in raw black soybean increased from 1.03 mg GAE/g, 0.29 mg CE/g, and 315.67 μg/g to 1.44 mg GAE/g, 0.64 mg CE/g, and 511.01 μg/g, respectively, by 4 days after germination. Changes to phenolic acid compositions can be divided into four groups, and the germination process can convert compounds to phenolic acid via anabolism and catabolism. The highest total free isoflavone content in germinated black soybean of 3,724.40 μg/g was observed at 4 days. Bound polyphenol, flavonoid, phenolic acid, and isoflavone contents decreased as the germination period increased. The highest total polyphenol content of 3.90 mg GAE/g, flavonoid content of 0.79 mg CE/g, phenolic acid content of 938.34 μg/g, and isoflavone content of 2,562.77 μg/g were observed after germination for four days and HHP treatment at 100 MPa for 24 h. In terms of isoflavone composition, the malonyl glycoside, β-glycoside, and acetylglycoside contents decreased, while the aglycone content increased as increasing germination periods and applied pressure. The highest proliferative effect of 147.43% is observed at four days germination and HHP treatment at 100 MPa for 24h. In the results of correlation analysis, correlation coefficients between some phenolic compound (gallic acid, homogentisic acid, gentisic acid, p-coumaric acid, ferulic acid, naringin, cinnamic acid, naringenin, biochanin, daidzein and genistein), and estrogenic activity of phenolic compound extract has the high positive correlation. The highest estrogenic activity in single phenolic compound of high positive correlation was observed at genistein of 127.54% treated by low concentration of 0.5 μg/mL. Therefore, maker compound of phenolic compound extracts in black soybean treated by germination and HHP was selected to genistein. Germinated black soybean had a estrogenic activity and that HHP treatment improved this activity, enhanced genistein and conversion of isoflavone may positively impact estrogenic activities.
2. Conversion, physiological characteristics and identification of bioactive peptide in black soybean after germination and high hydrostatic pressure treatment were investigated. The highest soluble protein content was in soybeans subjected to HHP (100 MPa) after germination (4 days). Germination and HHP treatment caused the degradation of high molecular weight proteins; we detected the highest content of <3 and <10 kDa peptides and free amino acids in extracts from pre-germinated soybeans that received HHP (150 MPa). The ABTS radical scavenging activity of soluble protein extracted by germinated black soybean (4 days) increase linearly between 1.21 and 3.58 mg equivalent ascorbic acid/g, and 0.69 and 2.02 mg equicalent Trolox/g with increasing applied pressure until 150 MPa. Pre-germinated (4 days) soybean extracts treated with HHP (150 MPa) significantly inhibited LPS-induced expression of inflammatory markers, nitric oxide of 25.01%, TNF-α of 76.78%, IL-1β of 58.99%, and IL-6 of 84.48% by RAW 264.7 macrophages. Therefore, anti-inflammatory active peptide was isolated and identified from protein extracts of high hydrostatic pressure treated and germinated black soybean (HGBP extracts) of pre-germinated (4 days) soybean treated with HHP (150 MPa). The HGBP extracts was first passed through the 30 kDa MWCO membranes and then 10 kDa, 3 kDa MWCO membranes, and the strong inhibitory effect was observed at PM 2 fraction (3~10 kDa fraction). The fraction PM1 and PM2 obtained from ultrafiltration with prominent anti-inflammatory activity was further separated in to six fraction (PM-S1 ~ PM-S6) using gel permeation column chromatography and MPLC, the highest NO inhibitory effects were dose-dependent observed in S4 fraction. The active fraction HGB-PM-S4 obtained from gel permeation chromatography was futher purified using 1st semi-preparative HPLC using C18 column chromatography, and the highest NO inhibitory effects were dose-dependent observed in S4-P1 fraction. The active fraction HGB-PM-S4-P1 obtained from 1st semi-preparative HPLC was father purified using 2nd semi-preparative HPLC using C18 column chromatography, and the highest NO inhibitory effects were dose-dependent observed in PM-S4-P1-p3 fraction. After isolation and purification of active peptide, anti-inflammatory activity on raw 264.7 was measured. The isolated and puri?ed anti-inflammatory compound was analyzed by UV, LC-MS, 1H and 13C NMR, COSY, HMBC and HSQC. The isolated compound was identified as tripeptide (Arg-Asp-Gly).
3. Conversion, physiological characteristics and identification of bioactive soyasaponin in black soybean after germination and high hydrostatic pressure treatment were investigated. The highest crude soyasaponin contents of 57.85 mg/g was in black soybean subjected to HHP (100 MPa for 24 h) after germination (4 days). Soyasaponin Bb was detected as major soyasaponin among B group soyasaponin of raw black soybean, soyasaponin Bb contents of raw black soybean and germinated black soybean increase from 94.55 and 111.98 mg/100g to 87.46 and 128.95 mg/100g after HHP at 100 MPa for 24 h. The highest anti-proliferative effect on all human cancer cell is observed at four days germination and HHP treatment at 150 MPa for 24 h, particularly, in human gastric cancer cell (AGS) cell line, crude soyasaponin extracts derived from germinated black soybean with HHP (150 MPa) at different concentration of 50~400 μg/mL showed stronger anticancer effect of 78.17~23.94% than other human cancer cell line. The lipid accumulation rate (% positive control) during 3T3-L1 adipocyte differentiation in germinated black soybean treated by HHP are in range of 93.25 ~ 65.95% at concertation of 400 μg/mL. The highest anti-obesity effect is observed at four days germination and HHP treatment at 150 MPa for 24 h. Also, in case of anti-inflammatory activity, germinated (4 days) soybean extracts treated with HHP (150 MPa) significantly inhibited LPS-induced expression of inflammatory markers, TNF-α of 51.90%, IL-1β of 30.93%, and IL-6 of 64.02% by RAW 264.7 macrophages. Therefore, anti-inflammatory active soyasaponin was isolated and identified from crude soyasaponin extracts of high hydrostatic pressure treated and germinated black soybean (HGBS extracts) of pre-germinated (4 days) soybean treated with HHP (150 MPa). The HGBS was separated to nine fractions (HGBS-C1~C9) and washing fraction (HGBS-C10) using 1st C18 column chromatography and MPLC, and The highest NO inhibitory effects were dose-dependent observed in C9 fraction. The fraction HGBS-C9 obtained from 1st MPLC with prominent anti-inflammatory activity was further separated to four fractions (HGBS-C9-c1~HGBS-C9-c4) and washing fraction (HGBS-C9-c5) using 2nd C18 column chromatography with MPLC, he highest NO inhibitory effects were dose-dependent observed in C9-c2 fraction. The HGBS-C9-c2 fraction was further purified to isolate the active compound with anti-inflammatory activity using semi-preparative HPLC, compared with unpurified fraction (C9-c2), the obtained two fractions (C9-c2-P5 and P6) more potent NO inhibitory activity, with NO concertation of 7.10 and 12.84 μM. The two-active fraction HGBS-C9-c2-P5 and P6 separated from 1st semi-preparative HPLC was further purified using 2nd semi-preparative HPLC C18 column chromatography, and anti-inflammatory active compound of HGBS were isolated to compound 1 (HGBS-C9-c2-P5-p2) and compound 2 (HGBS-C9-c2-P6-p3). After isolation and purification of active soyasaponin, anti-inflammatory activity on RAW 264.7 was measured. The isolated and puri?ed anti-inflammatory compound was analyzed by UV, LC-MS, 1H and 13C NMR, COSY, HMBC and HSQC. The isolated compound was identified as soyasaponin Bb (compound 1) and soyasaponin Bc (compound 2)
4. Identification on factor affecting bioactive compound conversion of black soybean after germination and high hydrostatic pressure treatment were investigated. Genistein, tripeptide (RGD) and soysaponin Bc content increase linearly with increasing HHP treatment time (0, 6, 12, 18 and 24 h) in control. However, enzyme inactivation so affected the change of genistein, tripeptide (RGD) and soyasaponin Bc content with HHP treatment time that did not increase or slightly increase in genistein content. Therefore, the cause enhanced physiological activity and marker compound (genistein, tripeptide (RGD) and soysaponin Bc) of germinated black soybean with HHP treatment are postulated that biological factor and enzyme activation play a major factor.
In conclusion, these results showed that germinated black soybean had an estrogenic and anti-inflammatory activity and that high hydrostatic pressure (HHP) treatment improved this activity, enhanced maker compound (genistein, tripeptide and soyasaponin Bc) and conversion of isoflavone, protein, and soyasaponin may positively impact physiological activity. Also, factor affecting maker compound conversion is enzyme activation of biosynthesis by germination and HHP treatment. This study provides valuable information on the application of HHP in combination with pre-germination for improving the utilization of phenolic compound, protein, saponin rich ingredient extracted black soybean as an effective physiological agent.

목차

CHAPTER I. Literature review and research objectives 1
1. Black soybean 2
2. Isoflavone 4
2.1. Chemical characteristics of isoflavone 4
2.2. Physiological activity of isoflavone 6
2.3. Biosynthesis of isoflavone 11
2.4. Conversion of isoflavone 13
3. Soy peptide 15
3.1. Chemical characteristics of soy-protein 15
3.2. Physiological activity of soy-peptide 16
3.3. Conversion of soy-peptide 19
4. Soyasaponin 22
4.1. Chemical characteristics of soyasaponin 22
4.2. Physiological activity of soyasaponin 25
4.3. Biosynthesis of soyasaponin 29
5. Germination 32
6. High hydrostatic pressure (HHP) 36
7. Research objective 43
References 44
CHAPTER II. Conversion and physiological characteristics of phenolic compound in black soybean after germination and high hydrostatic pressure treatment 72
Abstract 73
1. Introduction 75
2. Materials and methods 78
2.1. Materials 78
2.2. Sample Preparation 78
2.2.1. Germination 78
2.2.2. High hydrostatic pressure(HHP) treatment 79
2.2.3. Extraction of phenolic compound 79
2.3. Analysis of phenolic compound 82
2.3.1. Total polyphenol contents 82
2.3.2. Total flavonoid contents 82
2.3.3. Phenolic acid composition 83
2.3.4. Isoflavone composition 84
2.3.5. Anthocyanin composition 84
2.4. Physiological activities of phenolic compound 85
2.4.1. Anti-oxidant activity 85
2.4.2. Cell culture and cytotoxicity 86
2.4.3. Estrogenic activity in MCF-7 cancer cells 87
2.4.4. Anti-estrogenic activity in MCF-7 cancer cells 87
2.5. Statistical analysis 88
3. Results and discussion 89
3.1. Conversion characteristics of phenolic compound in black soybean 89
3.1.1. Total polyphenol and flavonoid contents 89
3.1.2. Phenolic acid composition 95
3.1.3. Isoflavone composition 104
3.1.4. Anthocyanin composition 114
3.2. Physiological activities of phenolic compound extract 120
3.2.1. Anti-oxidant activity 120
3.2.2. Estrogenic/anti-estrogenic activity in MCF-7 cancer cells 123
3.3. Correlation analysis for selection of marker compound 128
3.3.1. Correlation between phenolic compound and estrogenic activity 128
3.3.2. Estrogenic activity of single compound for selection of marker compound 132
References 135
CHAPTER III. Conversion, physiological characteristics and identification of bioactive peptide in black soybean after germination and high hydrostatic pressure treatment 142
Abstract 143
1. Introduction 145
2. Materials and methods 147
2.1. Materials 147
2.2. Sample Preparation 147
2.2.1. Germination 147
2.2.2. High hydrostatic pressure(HHP) treatment 147
2.2.3. Extraction of soluble protein 148
2.3. Analysis of protein and peptide characteristics 149
2.3.1. Soluble protein contents 149
2.3.2. Electrophoresis analysis (SDS PAGE) 149
2.3.3. Low molecular weight (<3 and <10 kDa) peptide contents 150
2.3.4. Free amino acid composition 150
2.4. Physiological activities of protein extract 151
2.4.1. Anti-oxidant activity 151
2.4.2. ACE inhibitory activity 152
2.4.3. Anti-inflammatory activities in raw 264.7 cell 153
2.5. Isolation and identification of active compound 154
2.5.1. Isolation in ultrafiltration (MWCO) 154
2.5.2. Gel permeation column chromatography (MPLC, Sepadex G15) 155
2.5.3. Purification of active compound by 1st semi-preparative HPLC 155
2.5.4. Purification of active compound by 2nd semi-preparative HPLC 156
2.5.5. Identification of active compound by UV, LC/MS and NMR 156
3. Result and discussion 163
3.1. Conversion characteristics of protein and peptide in black soybean 163
3.1.1. Extraction yield and soluble protein content 163
3.1.2. Electrophoresis analysis (SDS-PAGE) 166
3.1.3. Low molecular weight peptide content 169
3.1.4. Free amino acid composition 173
3.2. Physiological activities of protein extract 176
3.2.1. Anti-oxidant activity 176
3.2.2. ACE inhibitory activity 180
3.2.3. Anti-inflammatory activity in raw 264.7 cells 182
3.3. Isolation and identification of active compound 189
3.3.1. Isolation in ultrafiltration (MWCO) 189
3.3.2. Gel permeation column chromatography (MPLC, Sepadex G15) 191
3.3.3. Purification of active compound by 1st semi-preparative HPLC 195
3.3.4. Purification of active compound by 2nd semi-preparative HPLC 199
3.3.5. Identification of active compound by UV, LC/MS and NMR 205
4. References 214
CHAPTER IV. Conversion, physiological characteristics and identification of bioactive soyasaponin in black soybean after germination and high hydrostatic pressure treatment 222
Abstract 223
1. Introduction 225
2. Materials and methods 227
2.1. Materials 227
2.2. Sample Preparation 227
2.2.1. Germination 227
2.2.2. High hydrostatic pressure(HHP) treatment 228
2.2.3. Extraction of crude soyasaponin 228
2.3. Analysis of Soya-saponin contents 229
2.3.1. Crude soyasaponin contents 229
2.3.2. Soyasaponin composition 229
2.4. Physiological activities of crude soyasaponin extract 230
2.4.1. Anti-cancer activity against MCF-7, HCT-116, AGS and PC-3 cell 230
2.4.2. Anti-inflammatory activities in RAW 264.7 cell 232
2.4.3. Anti-obesity activities in 3T3-L1 adipocyte cell 234
2.5. Isolation and identification of active compound 235
2.5.1. Preparation of curde-sosaponin 235
2.5.2. 1st C18 column chromatography (MPLC) 236
2.5.3. 2nd C18 column chromatography (MPLC) 237
2.5.4. Purification of active compound by 1st semi-preparative HPLC 237
2.5.5. Purification of active compound by 2nd semi-preparative HPLC 238
2.5.6. Identification of active compound by UV, LC/MS and NMR 238
3. Result and discussion 245
3.1. Conversion characteristics of soyasaponin in black soybean 245
3.1.1. Extraction yield and crude soyasaponin content 245
3.1.2. Soyasaponin composition 248
3.2. Physiological activities of crude soyasaponin extract 254
3.2.1. Anti-cancer activity against MCF-7, HCT-116, AGS and PC-3 cell 254
3.2.2. Anti-obesity activities in 3T3-L1 adipocyte cell 263
3.2.3. Anti-inflammatory activity in RAW 264.7 cells 267
3.3. Isolation and identification of active compound 274
3.3.1. 1st C18 column chromatography (MPLC) 274
3.3.2. 2nd C18 column chromatography (MPLC) 249
3.3.3. Purification of active compound by 1st semi-preparative HPLC 283
3.3.4. Purification of active compound by 2nd semi-preparative HPLC 287
3.3.5. Identification of active compound by UV, LC/MS and NMR 294
3.4. Changes in maker peptide with different HHP and germination condition 314
3.5. Selection of marker compound 318
4. References 319
CHAPTER V. Identification on factors affecting maker compound conversion in black soybean after germination and high hydrostatic pressure treatment 327
Abstract 328
1. Introduction 329
2. Materials and methods 331
2.1. Materials 331
2.2. Sample preparation 331
2.2.1. Germination 331
2.2.2. Enzyme inactivation 332
2.2.3. High hydrostatic pressure(HHP) treatment 332
2.3. Analysis of maker compound contents 333
2.3.1. Isoflavone 333
2.3.2. Peptide 334
2.3.3. Soyasaponin 335
2.4. Statistical analysis 337
3. Result and discussion 337
3.1. Conversion characteristics of isoflavone with enzyme inactivation 337
3.2. Conversion characteristics of peptide with enzyme inactivation 340
3.3. Conversion characteristics of soyasaponin with enzyme inactivation 343
4. References 345
CHAPTER VI. Conclusion 347
SUMMARY IN KOREAN 353

최근 본 자료

전체보기

댓글(0)

0